BIOMAT Database Logo BIOMAT Database Logo

RS-61443 for treatment-resistant human liver rejection. 1993

G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
Department of Surgery, Baylor University Medical Center, Dallas, Texas.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
RS-61443 reverses acute allograft rejection in dogs.
October 1991, Surgery,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
RS-61443: successful rescue therapy in refractory renal rejection.
January 1992, Transplant international : official journal of the European Society for Organ Transplantation,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
RS-61443 reverses acute renal allograft rejection in dogs.
January 1992, Transplant international : official journal of the European Society for Organ Transplantation,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
The influence of RS-61443 on antibody-mediated rejection.
March 1992, Transplantation,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
RS-61443: rescue therapy in refractory kidney transplant rejection.
February 1993, Transplantation proceedings,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
RS-61443 prevents microvascular rejection of pancreatic islet xenografts.
February 1997, Transplantation,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
January 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection.
October 1992, Annals of surgery,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.
February 1995, Transplantation proceedings,
G B Klintmalm, and N L Ascher, and R W Busuttil, and M Deierhoi, and T A Gonwa, and R Kauffman, and S McDiarmid, and S Poplawski, and H Sollinger, and J Roberts
RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival.
February 1993, Transplantation proceedings,
Copied contents to your clipboard!